PubMed

Prostate Needle Biopsy Quality in Reduction by Dutasteride of Prostate Cancer Events Study: Worldwide Comparison of Improvement With Investigator Training and Centralized Laboratory Processing.

Bostwick DG, Qian J, Drewnowska K, Varvel S, Bostwick KC, Marberger M, Rittmaster RS.

Urology. 2009 Nov 24. [Epub ahead of print]PMID: 19942263 [PubMed - as supplied by publisher]Related articles

Pharmacological approaches to reducing the risk of prostate cancer.

Rittmaster RS, Fleshner NE, Thompson IM.

Eur Urol. 2009 May;55(5):1064-73. Epub 2009 Feb 5. Review.PMID: 19200641 [PubMed - indexed for MEDLINE]Related articles

Overexpression of 5 alpha-reductase type 1 increases sensitivity of prostate cancer cells to low concentrations of testosterone.

Thomas LN, Douglas RC, Rittmaster RS, Too CK.

Prostate. 2009 May 1;69(6):595-602.PMID: 19125422 [PubMed - indexed for MEDLINE]Related articles

5alpha-reductase inhibitors in benign prostatic hyperplasia and prostate cancer risk reduction.

Rittmaster RS.

Best Pract Res Clin Endocrinol Metab. 2008 Apr;22(2):389-402. Review.PMID: 18471794 [PubMed - indexed for MEDLINE]Related articles

The rationale for inhibiting 5alpha-reductase isoenzymes in the prevention and treatment of prostate cancer.

Tindall DJ, Rittmaster RS.

J Urol. 2008 Apr;179(4):1235-42. Epub 2008 Feb 20. Review. Erratum in: J Urol. 2008 Jun;179(6):2490. PMID: 18280514 [PubMed - indexed for MEDLINE]Related articlesFree article

The relationship between prostate inflammation and lower urinary tract symptoms: examination of baseline data from the REDUCE trial.

Nickel JC, Roehrborn CG, O'Leary MP, Bostwick DG, Somerville MC, Rittmaster RS.

Eur Urol. 2008 Dec;54(6):1379-84. Epub 2007 Nov 20.PMID: 18036719 [PubMed - indexed for MEDLINE]Related articlesFree article

Type 1 and type 2 5alpha-reductase expression in the development and progression of prostate cancer.

Thomas LN, Douglas RC, Lazier CB, Too CK, Rittmaster RS, Tindall DJ.

Eur Urol. 2008 Feb;53(2):244-52. Epub 2007 Nov 5. Review.PMID: 18006217 [PubMed - indexed for MEDLINE]Related articles

Levels of 5alpha-reductase type 1 and type 2 are increased in localized high grade compared to low grade prostate cancer.

Thomas LN, Douglas RC, Lazier CB, Gupta R, Norman RW, Murphy PR, Rittmaster RS, Too CK.

J Urol. 2008 Jan;179(1):147-51. Epub 2007 Nov 13.PMID: 17997435 [PubMed - indexed for MEDLINE]Related articles

Examination of the relationship between symptoms of prostatitis and histological inflammation: baseline data from the REDUCE chemoprevention trial.

Nickel JC, Roehrborn CG, O'leary MP, Bostwick DG, Somerville MC, Rittmaster RS.

J Urol. 2007 Sep;178(3 Pt 1):896-900; discussion 900-1. Epub 2007 Jul 16.PMID: 17632164 [PubMed - indexed for MEDLINE]Related articles

Fetal distribution of 5alpha-reductase 1 and 5alpha-reductase 2, and their input on human prostate development.

Lunacek A, Schwentner C, Oswald J, Fritsch H, Sergi C, Thomas LN, Rittmaster RS, Klocker H, Neuwirt H, Bartsch G, Radmayr C.

J Urol. 2007 Aug;178(2):716-21. Epub 2007 Jun 14.PMID: 17574609 [PubMed - indexed for MEDLINE]Related articles

The importance of dual 5alpha-reductase inhibition in the treatment of male pattern hair loss: results of a randomized placebo-controlled study of dutasteride versus finasteride.

Olsen EA, Hordinsky M, Whiting D, Stough D, Hobbs S, Ellis ML, Wilson T, Rittmaster RS; Dutasteride Alopecia Research Team.

J Am Acad Dermatol. 2006 Dec;55(6):1014-23.PMID: 17110217 [PubMed - indexed for MEDLINE]Related articles

DMP1 mutations in autosomal recessive hypophosphatemia implicate a bone matrix protein in the regulation of phosphate homeostasis.

Lorenz-Depiereux B, Bastepe M, Benet-Pagès A, Amyere M, Wagenstaller J, Müller-Barth U, Badenhoop K, Kaiser SM, Rittmaster RS, Shlossberg AH, Olivares JL, Loris C, Ramos FJ, Glorieux F, Vikkula M, Jüppner H, Strom TM.

Nat Genet. 2006 Nov;38(11):1248-50. Epub 2006 Oct 8.PMID: 17033625 [PubMed - indexed for MEDLINE]Related articles

Relationship among serum testosterone, sexual function, and response to treatment in men receiving dutasteride for benign prostatic hyperplasia.

Marberger M, Roehrborn CG, Marks LS, Wilson T, Rittmaster RS.

J Clin Endocrinol Metab. 2006 Apr;91(4):1323-8. Epub 2006 Jan 24.PMID: 16434455 [PubMed - indexed for MEDLINE]Related articlesFree article

The dual 5-alpha-reductase inhibitor dutasteride induces atrophic changes and decreases relative cancer volume in human prostate.

Iczkowski KA, Qiu J, Qian J, Somerville MC, Rittmaster RS, Andriole GL, Bostwick DG.

Urology. 2005 Jan;65(1):76-82.PMID: 15667867 [PubMed - indexed for MEDLINE]Related articles

Differential alterations in 5alpha-reductase type 1 and type 2 levels during development and progression of prostate cancer.

Thomas LN, Lazier CB, Gupta R, Norman RW, Troyer DA, O'Brien SP, Rittmaster RS.

Prostate. 2005 May 15;63(3):231-9.PMID: 15538746 [PubMed - indexed for MEDLINE]Related articles

Effect of dutasteride on the detection of prostate cancer in men with benign prostatic hyperplasia.

Andriole GL, Roehrborn C, Schulman C, Slawin KM, Somerville M, Rittmaster RS.

Urology. 2004 Sep;64(3):537-41; discussion 542-3.PMID: 15351586 [PubMed - indexed for MEDLINE]Related articles

Effect of the dual 5alpha-reductase inhibitor dutasteride on markers of tumor regression in prostate cancer.

Andriole GL, Humphrey P, Ray P, Gleave ME, Trachtenberg J, Thomas LN, Lazier CB, Rittmaster RS.

J Urol. 2004 Sep;172(3):915-9.PMID: 15310997 [PubMed - indexed for MEDLINE]Related articles

Dutasteride, the dual 5alpha-reductase inhibitor, inhibits androgen action and promotes cell death in the LNCaP prostate cancer cell line.

Lazier CB, Thomas LN, Douglas RC, Vessey JP, Rittmaster RS.

Prostate. 2004 Feb 1;58(2):130-44.PMID: 14716738 [PubMed - indexed for MEDLINE]Related articles

5alpha-reductase type 1 immunostaining is enhanced in some prostate cancers compared with benign prostatic hyperplasia epithelium.

Thomas LN, Douglas RC, Vessey JP, Gupta R, Fontaine D, Norman RW, Thompson IM, Troyer DA, Rittmaster RS, Lazier CB.

J Urol. 2003 Nov;170(5):2019-25.PMID: 14532845 [PubMed - indexed for MEDLINE]Related articles

[Dihydrotestosterone and the role of 5 alpha-reductase inhibitors in benign prostatic hyperplasia]

Bartsch G, Rittmaster RS, Klocker H.

Urologe A. 2002 Sep;41(5):412-24. Review. German. PMID: 12426858 [PubMed - indexed for MEDLINE]Related articles

Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia.

Bartsch G, Rittmaster RS, Klocker H.

World J Urol. 2002 Apr;19(6):413-25. Review.PMID: 12022710 [PubMed - indexed for MEDLINE]Related articles

Enhancement of bone mass in osteoporotic women with parathyroid hormone followed by alendronate.

Rittmaster RS, Bolognese M, Ettinger MP, Hanley DA, Hodsman AB, Kendler DL, Rosen CJ.

J Clin Endocrinol Metab. 2000 Jun;85(6):2129-34.PMID: 10852440 [PubMed - indexed for MEDLINE]Related articlesFree article

Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia.

Bartsch G, Rittmaster RS, Klocker H.

Eur Urol. 2000 Apr;37(4):367-80. Review.PMID: 10765065 [PubMed - indexed for MEDLINE]Related articles

Prostatic involution in men taking finasteride is associated with elevated levels of insulin-like growth factor-binding proteins (IGFBPs)-2, -4, and -5 .

Thomas LN, Wright AS, Lazier CB, Cohen P, Rittmaster RS.

Prostate. 2000 Feb 15;42(3):203-10.PMID: 10639191 [PubMed - indexed for MEDLINE]Related articles

The utility of tissue transglutaminase as a marker of apoptosis during treatment and progression of prostate cancer.

Rittmaster RS, Thomas LN, Wright AS, Murray SK, Carlson K, Douglas RC, Yung J, Messieh M, Bell D, Lazier CB.

J Urol. 1999 Dec;162(6):2165-9.PMID: 10569613 [PubMed - indexed for MEDLINE]Related articles

Androgen-induced regrowth in the castrated rat ventral prostate: role of 5alpha-reductase.

Wright AS, Douglas RC, Thomas LN, Lazier CB, Rittmaster RS.

Endocrinology. 1999 Oct;140(10):4509-15.PMID: 10499505 [PubMed - indexed for MEDLINE]Related articlesFree article

Antiandrogen treatment of polycystic ovary syndrome.

Rittmaster RS.

Endocrinol Metab Clin North Am. 1999 Jun;28(2):409-21. Review.PMID: 10352926 [PubMed - indexed for MEDLINE]Related articles

Insulin-like growth factor binding protein 5 is associated with involution of the ventral prostate in castrated and finasteride-treated rats.

Thomas LN, Cohen P, Douglas RC, Lazier C, Rittmaster RS.

Prostate. 1998 Jun 1;35(4):273-8.PMID: 9609550 [PubMed - indexed for MEDLINE]Related articles

Role of the ovary in the adrenal androgen excess of hyperandrogenic women.

Azziz R, Rittmaster RS, Fox LM, Bradley EL Jr, Potter HD, Boots LR.

Fertil Steril. 1998 May;69(5):851-9.PMID: 9591492 [PubMed - indexed for MEDLINE]Related articles

Effect of methimazole, with or without L-thyroxine, on remission rates in Graves' disease.

Rittmaster RS, Abbott EC, Douglas R, Givner ML, Lehmann L, Reddy S, Salisbury SR, Shlossberg AH, Tan MH, York SE.

J Clin Endocrinol Metab. 1998 Mar;83(3):814-8.PMID: 9506733 [PubMed - indexed for MEDLINE]Related articlesFree article

Testolactone-associated high androgen levels, a pharmacologic effect or a laboratory artifact?

Cummings EA, Salisbury SR, Givner ML, Rittmaster RS.

J Clin Endocrinol Metab. 1998 Mar;83(3):784-7.PMID: 9506727 [PubMed - indexed for MEDLINE]Related articlesFree article

5alpha-reductase inhibitors.

Rittmaster RS.

J Androl. 1997 Nov-Dec;18(6):582-7. Review. No abstract available. PMID: 9432130 [PubMed - indexed for MEDLINE]Related articlesFree article

Polycystic ovary syndrome, hyperthecosis and the menopause.

Rittmaster RS.

Clin Endocrinol (Oxf). 1997 Feb;46(2):129-30. No abstract available. PMID: 9135691 [PubMed - indexed for MEDLINE]Related articles

Hirsutism.

Rittmaster RS.

Lancet. 1997 Jan 18;349(9046):191-5. Review. No abstract available. PMID: 9111556 [PubMed - indexed for MEDLINE]Related articles

Relative potency of testosterone and dihydrotestosterone in preventing atrophy and apoptosis in the prostate of the castrated rat.

Wright AS, Thomas LN, Douglas RC, Lazier CB, Rittmaster RS.

J Clin Invest. 1996 Dec 1;98(11):2558-63.PMID: 8958218 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of methimazole with or without exogenous L-thyroxine on serum concentrations of thyrotropin (TSH) receptor antibodies in patients with Graves' disease.

Rittmaster RS, Zwicker H, Abbott EC, Douglas R, Givner ML, Gupta MK, Lehmann L, Reddy S, Salisbury SR, Shlossberg AH, Tan MH, York SE.

J Clin Endocrinol Metab. 1996 Sep;81(9):3283-8.PMID: 8784084 [PubMed - indexed for MEDLINE]Related articles

Dose-response effect of depot leuprolide acetate on serum androgens in hirsute women.

Rittmaster RS, Arab DM, Lehman L.

Fertil Steril. 1996 May;65(5):912-5.PMID: 8612847 [PubMed - indexed for MEDLINE]Related articles

Evidence for atrophy and apoptosis in the prostates of men given finasteride.

Rittmaster RS, Norman RW, Thomas LN, Rowden G.

J Clin Endocrinol Metab. 1996 Feb;81(2):814-9.PMID: 8636309 [PubMed - indexed for MEDLINE]Related articles

Gonadotropin-releasing hormone (GnRH) agonists and estrogen/progestin replacement for the treatment of hirsutism: evaluating the results.

Rittmaster RS.

J Clin Endocrinol Metab. 1995 Dec;80(12):3403-5. No abstract available. PMID: 8530572 [PubMed - indexed for MEDLINE]Related articles

Clinical review 73: Medical treatment of androgen-dependent hirsutism.

Rittmaster RS.

J Clin Endocrinol Metab. 1995 Sep;80(9):2559-63. Review.PMID: 7673394 [PubMed - indexed for MEDLINE]Related articles

Severe cholestatic jaundice in uncomplicated hyperthyroidism treated with methimazole.

Arab DM, Malatjalian DA, Rittmaster RS.

J Clin Endocrinol Metab. 1995 Apr;80(4):1083-5. No abstract available. PMID: 7714072 [PubMed - indexed for MEDLINE]Related articles

Evidence for atrophy and apoptosis in the ventral prostate of rats given the 5 alpha-reductase inhibitor finasteride.

Rittmaster RS, Manning AP, Wright AS, Thomas LN, Whitefield S, Norman RW, Lazier CB, Rowden G.

Endocrinology. 1995 Feb;136(2):741-8.PMID: 7835306 [PubMed - indexed for MEDLINE]Related articles

Clinical relevance of testosterone and dihydrotestosterone metabolism in women.

Rittmaster RS.

Am J Med. 1995 Jan 16;98(1A):17S-21S. Review.PMID: 7825635 [PubMed - indexed for MEDLINE]Related articles

Effect of finasteride on adrenal steroidogenesis in men.

Rittmaster RS, Antonian L, New MI, Stoner E.

J Androl. 1994 Jul-Aug;15(4):298-301.PMID: 7982796 [PubMed - indexed for MEDLINE]Related articlesFree article

Finasteride.

Rittmaster RS.

N Engl J Med. 1994 Jan 13;330(2):120-5. Review. No abstract available. PMID: 7505051 [PubMed - indexed for MEDLINE]Related articles

Androgen metabolism in men receiving finasteride before prostatectomy.

Norman RW, Coakes KE, Wright AS, Rittmaster RS.

J Urol. 1993 Nov;150(5 Pt 2):1736-9.PMID: 7692110 [PubMed - indexed for MEDLINE]Related articles

Use of gonadotropin-releasing hormone agonists in the treatment of hyperandrogenism.

Rittmaster RS.

Clin Obstet Gynecol. 1993 Sep;36(3):679-89. Review. No abstract available. PMID: 8403614 [PubMed - indexed for MEDLINE]Related articles

The role of adrenal hyperandrogenism, insulin resistance, and obesity in the pathogenesis of polycystic ovarian syndrome.

Rittmaster RS, Deshwal N, Lehman L.

J Clin Endocrinol Metab. 1993 May;76(5):1295-300.PMID: 8388405 [PubMed - indexed for MEDLINE]Related articles

Androstanediol glucuronide production in human liver, prostate, and skin. Evidence for the importance of the liver in 5 alpha-reduced androgen metabolism.

Rittmaster RS, Zwicker H, Thompson DL, Konok G, Norman RW.

J Clin Endocrinol Metab. 1993 Apr;76(4):977-82.PMID: 8473413 [PubMed - indexed for MEDLINE]Related articles

Androgen conjugates: physiology and clinical significance.

Rittmaster RS.

Endocr Rev. 1993 Feb;14(1):121-32. Review. No abstract available. PMID: 8491151 [PubMed - indexed for MEDLINE]Related articles